GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Vectus Biosystems Ltd (ASX:VBS) » Definitions » PensionAndRetirementBenefit
Switch to:

Vectus Biosystems (ASX:VBS) PensionAndRetirementBenefit

: A$0.00 Mil (As of Dec. 2022)
View and export this data going back to 2016. Start your Free Trial

Vectus Biosystems's PensionAndRetirementBenefit for the quarter that ended in Dec. 2022 was A$0.00 Mil.

Vectus Biosystems's quarterly PensionAndRetirementBenefit increased from Dec. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil) but then declined from Jun. 2022 (A$0.00 Mil) to Dec. 2022 (A$0.00 Mil).

Vectus Biosystems's annual PensionAndRetirementBenefit increased from Jun. 2020 (A$0.00 Mil) to Jun. 2021 (A$0.00 Mil) but then stayed the same from Jun. 2021 (A$0.00 Mil) to Jun. 2022 (A$0.00 Mil).

Vectus Biosystems PensionAndRetirementBenefit Historical Data

The historical data trend for Vectus Biosystems's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Premium Member Only Premium Member Only 0.01 - - - -

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
PensionAndRetirementBenefit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Vectus Biosystems PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

Vectus Biosystems (ASX:VBS) Business Description

Vectus Biosystems logo
Traded in Other Exchanges
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines